Christine Lindenboom | Vice President of Investor Relations & Corporate Communications |
John Maraganore | Chief Executive Officer |
Barry Greene | President |
Akshay Vaishnaw | President of R&D |
Manmeet Soni | Chief Financial Officer |
Paul Matteis | Stifel |
Alan Carr | Needham & Company |
Emma Nealon | Cantor Fitzgerald |
Ritu Baral | Cowen |
Dave Lebowitz | Morgan Stanley |
Gena Wang | Barclays |
Whitney Ijem | Guggenheim |
Mani Foroohar | SVB Leerink |
Vincent Chen | Bernstein |
Ted Tenthoff | Piper Jaffray |
Terence Flynn | Goldman Sachs |
Ladies and gentlemen, thank you for standing by. Welcome to the Alnylam Pharmaceuticals Conference Call Fourth Quarter and Full Year 2018 Financial Results. There will be a question-and-answer session to follow. Please be advised that this call is being taped at the company's request. I would now like to turn the call over to the company.